Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
Principles for designing future regimens for multidrug-resistant tuberculosis.
Brigden G, Nyang'wa BT, du Cros P, Varaine F, Hughes J, Rich M, Horsburgh CR Jr, Mitnick CD, Nuermberger E, McIlleron H, Phillips PP, Balasegaram M. Brigden G, et al. Bull World Health Organ. 2014 Jan 1;92(1):68-74. doi: 10.2471/BLT.13.122028. Epub 2013 Oct 25. Bull World Health Organ. 2014. PMID: 24391302 Free PMC article.
Multidrug-resistant tuberculosis.
Nyang'wa BT, Berry C, Fielding K, Nunn AJ. Nyang'wa BT, et al. Lancet. 2019 Jul 27;394(10195):298-299. doi: 10.1016/S0140-6736(19)30691-9. Lancet. 2019. PMID: 31354136 No abstract available.
Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan.
du Cros P, Khamraev A, Tigay Z, Abdrasuliev T, Greig J, Cooke G, Herboczek K, Pylypenko T, Berry C, Ronnachit A, Lister D, Dietrich S, Ariti C, Safaev K, Nyang'wa BT, Parpieva N, Tillashaikhov M, Achar J. du Cros P, et al. ERJ Open Res. 2021 Feb 8;7(1):00537-2020. doi: 10.1183/23120541.00537-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33585652 Free PMC article.
Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan.
Wharton-Smith A, Horter S, Douch E, Gray N, James N, Nyang'wa BT, Singh J, Nusratovna PN, Tigay Z, Kazounis E, Allanazarova G, Stringer B. Wharton-Smith A, et al. Among authors: nyang wa bt. Trials. 2021 Dec 4;22(1):881. doi: 10.1186/s13063-021-05850-0. Trials. 2021. PMID: 34863253 Free PMC article. Clinical Trial.
21 results